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Abstract
Background:  Acute phase proteins haptoglobin (Hp), serum amyloid A (SAA) and
lipopolysaccharide binding protein (LBP) have suggested to be suitable inflammatory markers for
bovine mastitis. The aim of the study was to investigate acute phase markers along with clinical
parameters in two consecutive intramammary challenges with Escherichia coli and to evaluate the
possible carry-over effect when same animals are used in an experimental model.
Methods: Mastitis was induced with a dose of 1500 cfu of E. coli in one quarter of six cows and
inoculation repeated in another quarter after an interval of 14 days. Concentrations of acute phase
proteins haptoglobin (Hp), serum amyloid A (SAA) and lipopolysaccharide binding protein (LBP)
were determined in serum and milk.
Results: In both challenges all cows became infected and developed clinical mastitis within 12
hours of inoculation. Clinical disease and acute phase response was generally milder in the second
challenge. Concentrations of SAA in milk started to increase 12 hours after inoculation and peaked
at 60 hours after the first challenge and at 44 hours after the second challenge. Concentrations of
SAA in serum increased more slowly and peaked at the same times as in milk; concentrations in
serum were about one third of those in milk. Hp started to increase in milk similarly and peaked
at 36–44 hours. In serum, the concentration of Hp peaked at 60–68 hours and was twice as high
as in milk. LBP concentrations in milk and serum started to increase after 12 hours and peaked at
36 hours, being higher in milk. The concentrations of acute phase proteins in serum and milk in the
E. coli infection model were much higher than those recorded in experiments using Gram-positive
pathogens, indicating the severe inflammation induced by E. coli.
Conclusion: Acute phase proteins would be useful parameters as mastitis indicators and to assess
the severity of mastitis. If repeated experimental intramammary induction of the same animals with
E. coli is used in cross-over studies, the interval between challenges should be longer than 2 weeks,
due to the carry-over effect from the first infection.
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Background
Environmental mastitis caused by coliform bacteria is an
increasing problem for the dairy industry in many coun-
tries [1,2]. Mastitis caused by Escherichia coli is typically
self-limiting and of short duration, but can be associated
with severe clinical signs, reductions in milk yield and
heavy tissue damage to mammary gland [3-5]. The strate-
gies for preventing coliform mastitis include hygiene
measures and in some countries prophylactic immuniza-
tion. Incidence and severity of clinical signs of coliform
mastitis were reduced using Escherichia coli core antigen
vaccine [6-8].
Bacterial lipopolysaccharide (LPS), from the cell wall of
Gram-negative bacteria, is considered to cause most
pathophysiological reactions during coliform mastitis. In
coliform mastitis, the severity of clinical signs is consid-
ered to depend mainly on the host response [3]. LPS trig-
gers formation of proinflammatory cytokines, produced
predominantly by monocytes and macrophages [9,10].
Cytokines initiate the inflammatory response, which
induces the acute phase response (APR) by activating the
production of acute phase proteins (APP) such as serum
amyloid-A (SAA), haptoglobin (Hp) and LPS-binding
protein (LBP) [11-15].
Concentrations of two major bovine APP, Hp and SAA,
were shown to increase in serum [16,13,14,17,18] as in
milk during mastitis [11,13,19,20]. Hp is mostly secreted
by liver cells, but also local production has been demon-
strated [15,21]. The other major APP of the cow, SAA, is
synthesized by the liver, but also locally by the mammary
gland [22-24]. Hp and SAA have been suggested to be suit-
able inflammatory markers for bovine mastitis [25,26].
LBP is a relatively new inflammatory indicator for mastitis
[12].
The aim of this study was to investigate APR in an experi-
mental E. coli mastitis model with mastitis induced twice
at an interval of two weeks and to evaluate the possible
carry-over effect when the same animals are used. Several
APP were monitored in serum and milk to study the host
response to the bacterial challenge.
Methods
Animals and experimental design
Seven clinically healthy lactating (on average 92 days
from parturition, range 30–123 days) primiparous cows
(three Finnish Ayrshire and four Holstein-Friesian) were
used as experimental animals. Experimental Escherichia
coli mastitis was induced in one quarter of each cow twice
at an interval of 14 days. The cows were housed in tie stalls
and accustomed to the environment and handling for two
weeks before the experiment. The cows were fed with
good quality hay, silage and concentrated grain according
to their energy requirements. Water was available ad libi-
tum. The cows were milked twice a day, at 8 am and 4 pm.
The milk composite somatic cell count (SCC) of the cows
was less than 100 000 cells/ml and no bacteria were iso-
lated from the milk before the challenges. Mean SCC in
the milk of the test quarter before the first challenge was
15 200 cells/ml (range 3 000–57 000 cells/ml) and before
the second challenge 14 300 cells/ml (range 5 000–25
000 cells/ml), respectively. Milk yield of the inoculated
quarter before the first challenge was on average 3.8 kg
(range 3–5.1 kg) and before the second 3.8 kg (range 3–
5.3 kg). Mean total daily milk yield was 24.2 kg before the
first challenge (range 18.6–31.5 kg) and 22.9 kg before
the second challenge (range 15.7–33.0 kg). All cows were
treated with flunixin meglumine (dose 2.2 mg/kg) once at
12 hours post challenge (PC), when the first clinical signs
were observed, to comply with animal welfare require-
ments. The Ethics Committee of the Faculty of Veterinary
Medicine, Helsinki, Finland approved the study protocol.
The Escherichia coli strain, FT238, isolated from clinical
mastitis and used previously, was selected for experimen-
tal inductions [27,28]. The inoculation dose was prepared
as described before [29,28]. One udder quarter of each
cow was infused via the teat canal with an average dose of
1500 cfu of E. coli (range 1400–1600 cfu) and the inocu-
lation was repeated after 14 days in another udder quarter.
The quarters were infused four hours after the evening
milking.
Blood and milk samples
Blood samples were collected from the jugular vein of
each cow before challenge and 12, 16, 20, 24, 36, 44, 60,
68 and 156 hours post challenge (PC). Serum was sepa-
rated and kept frozen at -70°C for later determinations of
SAA, Hp and LBP. EDTA blood was collected for leukocyte
count (WBC) determination. Aseptic milk samples were
collected from the experimental and contralateral quarter
before the challenge and 12, 20, 36, 44, 60, 68, 84,108,
132 and 156 hours PC for bacteriology, SCC, N-asetyl-β-
D-glucosaminidase (NAGase) activity, SAA, Hp and LBP
determinations.
Clinical observations
Systemic and local signs were monitored throughout the
experimental period of 6 days: during the first day every 4
hours and thereafter twice a day at the time of milking.
Heart rate, rectal temperature, rumen motility, appetite
and general attitude were evaluated. The systemic signs
were scored on a three point scale, 1 = no signs to 3 =
severe signs; half values were also used [26]. The udder
was palpated for soreness, swelling, hardness and temper-
ature, and appearance of milk assessed visually for clots,
colour changes and changes in consistency. The local
signs were scored on the same scale as systemic signs: milkActa Veterinaria Scandinavica 2008, 50:18 http://www.actavetscand.com/content/50/1/18
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1 = normal to 3 = serous or clotty milk and udder 1 = no
changes to 3 = severe swelling and soreness in the quarter.
Cows with scores ≤1.5 were recorded as having mild mas-
titis, those with scores >1.5 but ≤2.5 as having moderate
mastitis and those with scores from >2.5 to 3 as having
severe mastitis. The milk yield from the experimental
quarter and the total milk yield were measured before
challenge and thereafter until the end of the experimental
period.
Analytical methods for indicators of inflammation
Bacterial counts in the milk were determined by prepara-
tion of 10-fold dilution series of milk in sterile saline. Bac-
teria were cultured on blood agar at 37°C for 24 hours
using serial dilutions and counted using a routine plate
count method. Milk SCC was measured in Valio Ltd. Lab-
oratories, Finland using a fluoro-optical method (Fosso-
matic-instrument, Foss Electric, Hillerød, Denmark). SCC
values over 30 × 106 cells/ml were recorded as 30 × 106
cells/ml. Milk NAGase activity was measured using the
fluorogenic method of Kitchen and co-workers (1978)
[30] with a microplate modification developed by Mattila
[31]. Inter-assay and intra-assay CVs for NAGase activity
were for the high control <5% and for the low control 7%.
Values over 2.5 pmol/min/ml were expressed as >2.5
pmol/min/ml.
The concentration of SAA in serum and milk was deter-
mined by using a commercial ELISA test (Tridelta Devel-
opment, Wicklow, Ireland). Serum and milk samples were
initially diluted 1:500 and 1:50, respectively. For very high
SAA values, samples were diluted as necessary up to
1:5000 for serum samples and up to 1:15000 for milk
(maximum concentrations 750 mg/l and 2250 mg/l,
respectively). The inter-assay and intra-assay coefficients
of variation (CV) for SAA analysis were <10% and <7%.
Milk and serum Hp concentrations were determined
using the method based on the ability of Hp to bind to
haemoglobin [32] and using tetramethylbenzidine as the
substrate [33]. The assay is aimed for determining of Hp
in serum but was here adapted to be used for milk [34].
Optical densities of the formed complex were measured
using a spectrophotometer at 450 nm (Multiskan MS,
Labsystems, Vantaa, Finland). Lyophilized bovine acute
phase serum was used as a standard and calibration was
according to the European Union concerted action on
standardization of animal APPs (number QLK5-CT-1999-
0153). The inter-assay and intra-assay CVs for Hp analysis
were <10% and <12%.
LBP concentrations in serum and milk were determined
with a commercially available LBP ELISA kit, cross-react-
ing with bovine LBP (LBP ELISA for various species,
Hycult Biotechnology, Uden, The Netherlands). Milk and
serum samples were initially diluted 1:500 and 1:1000
respectively, and assayed following the instructions of the
manufacturer. For high concentrations, milk was diluted
up to 1:5000 and serum up to 1:2000. The optical density
at 450 nm and a correction wavelength of 550 nm were
measured on a spectrophotometer (Multiskan MS, Lab-
systems). The LBP concentration was determined by
extrapolation using linear regression from a standard
curve of known human LBP concentrations. The inter-
assay and intra-assay CVs for LBP analysis were <13% and
<9%.
Leukocyte count (WBC) was determined 24 hours after
sampling using an automated multiparameter analyzer
with software for animal samples (Cell-Dyn 3700 System,
Abbot Diagnostic Division, Abbot Park, IL, USA).
Statistical analysis
Linear random-intercept models were used to explore
time trend differences between challenge times in milk
production data, milk SCC, milk NAGase, WBC and all
APP measurements. Bacterial counts in milk and local and
systemic sign differences between challenges were tested
using generalized linear mixed models in which a Poisson
distribution was used for response variables. The cow was
included as a random factor. Polynomials for time in
increasing order and their interactions with challenge
occasion were fixed factors and were added until signifi-
cant, for modeling changes in time at both challenges.
Overall time trend differences between challenges were
tested with an F-test. As there were different intervals
between sampling, isotropic spatial exponential correla-
tion structures were used for modeling serial correlations
of repeated measurements within cows. Logarithmic
transformation of milk SCC, NAGase and APPs in milk
and serum was used. The nlme-package [35] with statisti-
cal software R 2.5.0 [36] was used for fitting linear ran-
dom-intercept models and generalized linear mixed
models were fitted using the GLIMMIX procedure [37]
software with the SAS/STAT 9.1 (SAS Institute Inc., Cary,
NC, USA).
Results
Clinical findings
After both challenges all cows became infected and devel-
oped clinical mastitis within 12 hours after inoculation.
One cow was excluded from the experiment because of
acute spontaneous coliform mastitis after the first chal-
lenge. All cows showed systemic and local inflammatory
response after both challenges. Systemic response began
within 12 hours, being moderate in all cows at 12 hours
PC based on the clinical severity scoring system. Systemic
signs disappeared in cows after both challenges until 36
hours PC. Local signs were still recorded at the end of the
experimental period of 6 d after the first challenge, but
disappeared by 60 hours PC after the second challenge. InActa Veterinaria Scandinavica 2008, 50:18 http://www.actavetscand.com/content/50/1/18
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both challenges, cows developed a similar systemic
response, but their local responses varied more. After the
second challenge, local clinical signs were significantly
milder (p < 0.05) but no statistically significant differences
were noted in systemic signs (Figure 1).
Milk production
The daily milk yield was at its lowest 36 hours PC after
both challenges, being on average 16 kg after the first chal-
lenge and 17.1 kg after the second. After 6 days PC the
total milk yields in both groups returned to pre-chal-
lenged levels. The total daily milk yield during the experi-
mental period was significantly higher for the second
challenge (p < 0.05). The milk yield of the infected quarter
was lowest at 36 hours PC, being 1.1 kg (range 0 – 2.5 kg)
after the first challenge and 1.4 kg (range 0.8 – 2.5 kg)
after the second. The milk yield from infected quarters was
significantly higher after the second challenge (p < 0.05;
Figure 2).
Bacterial counts in milk
Bacterial counts in the milk of the challenged quarters
peaked at 12 hours PC at both challenge times, being on
average 18.1 × 106 cfu/ml in the first challenge and 6800
cfu/ml in the second challenge. Bacteria were still isolated
in low numbers from one cow (80 cfu/ml) 6 days PC after
the first challenge, but after the second challenge were
eliminated totally in all cows within 68 hours. Overall
bacterial counts were lower at the second challenge (p <
0.05; Figure 3).
Mean scores for systemic and local clinical signs in two con- secutive E. coli challenges Figure 1
Mean scores for systemic and local clinical signs in 
two consecutive E. coli challenges. Systemic and local 
clinical signs following two consecutive intramammary chal-
lenges with E. coli at an interval of two weeks. Values are 
mean scores for six cows with SEM represented by vertical 
bars.
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Mean total daily milk yield and milk yield of the experimen- tally infected quarter in two consecutive E. coli challenges Figure 2
Mean total daily milk yield and milk yield of the 
experimentally infected quarter in two consecutive 
E. coli challenges. Total daily milk yield (kg) and milk yield 
(kg) of the experimentally infected quarter following two 
consecutive intramammary challenges with E. coli at an inter-
val of two weeks. Values are means for six cows with SEM 
represented by vertical bars.
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Indicators of inflammation in the milk
Milk SCC of the challenged quarters started to increase
from the baseline values after both challenges within 12
hours and reached the maximum level at 20 hours PC,
being over 25 × 106 cells/ml after first challenge and 20.7
× 106 cells/ml after the second. In both groups SCC grad-
ually decreased after challenges. At the end of the experi-
mental period of 6 d, SCC was on average 5.8 × 106 cells/
ml (range 541 000 – 18.1 × 106 cells/ml) after the first
challenge and 541 000 cells/ml (range 256 000–705 000
cells/ml) after the second challenge. The difference
between the groups was not statistically significant (Figure
3).
NAGase activity of the milk after both challenges peaked
at 20 hours PC, being on average 1.95 pmol/min/μl
(range 0.65 – >2.5) after the first challenge and 1.90
pmol/min/μl after the second (range 0.63 – >2.5). After
the first challenge NAGase activity remained elevated over
the experimental period, but returned to the baseline
value by this time after the second challenge. The differ-
ence between the challenges was not statistically signifi-
cant (Figure 4). Milk SCC and NAGase activity in the
contralateral control quarters remained at the pre-chal-
lenged levels in both groups after both challenges.
Before the first challenge, mean milk SAA concentrations
were 7.1 mg/l ± 11.0 mg/l and before the second, 0.4 mg/
l ± 0.4 mg/l. Milk SAA concentrations in both groups
started to increase after 12 hours PC and reached the max-
imum (mean 1315.9 mg/l ± 947.3) at 60 hours PC after
the first challenge and at 44 hours PC (mean 925.0 mg/l
± 609.1) after the second challenge. After the second chal-
lenge, SAA concentration decreased faster: mean concen-
tration by the end of the experimental period was 16.6 ±
11.9 mg/l. Milk Hp started to increase after both chal-
lenges 12 hours PC and peaked at 44 hours at 0.60 g/l (±
0.49 g/l) after the first challenge and at 36 hours at 0.32 g/
l (± 0.17 g/l) after second challenge. The Hp concentra-
tions in milk returned to background levels within 156
hours after both challenges, faster after the second chal-
lenge. LBP concentrations in milk started to rise 12 hours
PC and peaked at 36 hours PC, being on average 203.5 ±
44.3 mg/l after the first challenge and 169.0 ± 167.7 mg/l
after the second. LBP was still increasing 6 d after the first
challenge, but had reached the pre-challenge level by that
time after the second challenge. Statistically significant
differences between the two challenges were established
for milk SAA (p < 0.05) and Hp (p < 0.05).
Indicators of inflammation in blood
The concentrations of SAA in serum started to rise slowly
after challenges until 24 hours PC, concentrations peaking
after the first challenge by 60 hours PC (mean 447.9 mg/
l ± 164.8) and after the second challenge by 44 hours PC
(mean 307.1 mg/l ± 66.2). In both groups the SAA in
serum subsequently decreased gradually, but had not
reached the base levels by the end of the experimental
period. However, there were no statistically significant dif-
ferences between the two challenges.
The same trend was found for serum Hp concentrations,
which started to rise after 24 hours and peaked at 60–68
hours after both challenges, reaching, on average, 1.70 g/
l (± 0.68) in the first challenge and 1.13 g/l (± 0.08) in the
second challenge. Haptoglobin concentrations in serum
then decreased and were on average 0.61 g/l (± 0.54) by 6
days PC after the first challenge and 0.23 g/l (± 0.10) after
the second challenge. Serum Hp concentrations were sig-
nificantly lower in the later challenge (p < 0.001; Figure 5)
Mean somatic cell counts and bacterial counts in milk in two  consecutive E. coli challenges Figure 3
Mean somatic cell counts and bacterial counts in milk 
in two consecutive E. coli challenges. Mean somatic cell 
counts (log cells/ml) and bacterial counts (log cfu/ml) in milk 
following two consecutive intramammary challenges with E. 
coli at an interval of two weeks. Values are means for six 
cows with SEM represented by vertical bars.
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The basic concentrations of serum LBP before the chal-
lenges were on average 10.8 mg/l (± 7.7) after the first
challenge and 10.0 mg/l (± 6.4) after the second. Serum
LBP started to increase rapidly in both groups and peaked
at 36 hours PC, being on average 148.6 mg/l (± 41.8) after
the first challenge and 108.9 mg/l (± 31.6) after the sec-
ond. No statistically significant difference was recorded
between the challenges (Figure 5).
WBC started to decrease after both challenges, being at the
lowest 12 h PC (on average 2.03 × 109 cells/l at first and
2.97 × 109 cells/l at second challenge), then starting to
increase, being at its highest an average of 8.61 × 109 cells/
l (range 4.85–10.9 × 109 cells/l) at 60 hours after the first
challenge and at 24 hours 10.47 × 109 cells/l (8.02–15.8 ×
109 cells/l) after the second. WBC levels were higher after
the second challenge during the whole experiment. The
difference in WBC levels was statistically significant (p <
0.05; Figure 5).
Discussion
Using a repeated challenge model at a short interval in the
same cows could reveal possible carry-over effects of the
previous intramammary infection by the same pathogen
[22]. In our study using two consecutive intramammary
challenges with E. coli, all cows became infected and
developed local (swelling, soreness, clots in milk) and sys-
temic inflammatory reaction. Cows had a moderate sys-
temic clinical response to both challenges, but after the
second challenge local signs were significantly milder and
disappeared faster. The same pattern was seen for the indi-
cators of inflammation, the difference being statistically
significant for serum and milk Hp, milk SAA, and WBC.
Milk production returned to the pre-challenge level signif-
icantly faster after the second challenge. In the present
Concentrations of SAA, LBP, Hp and NAGase activity in milk in two consecutive E. coli challenges Figure 4
Concentrations of SAA, LBP, Hp and NAGase activity in milk in two consecutive E. coli challenges. Mean con-
centrations of SAA, LBP, Hp and NAGase activity in milk following two consecutive intramammary challenges with E. coli at an 
interval of two weeks. Values are means for six cows with SEM represented by vertical bars.
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study, one dose of anti-inflammatory medication was
used at 12 h PC which may slightly affect the inflamma-
tory response but given at both challenges, allows com-
parison of the two subsequent challenges.
In previous studies using an experimentally induced E. coli
mastitis model and a 3 week interval, the disease was
slightly milder after the second challenge, but the differ-
ences were not statistically significant [29,27,28].
Repeated challenges with LPS at 24 h intervals were stud-
ied by Rainard & Paape [38], and observed sensitization of
the mammary gland followed the first contact with a
moderate dose of LPS. They did not find systemic signs
after the first LPS challenge, which was speculated to be
due to too small an amount of LPS to trigger the systemic
inflammation response, but after the second infusion 24
hours later the systemic signs were observed. We used rel-
atively large numbers of live E. coli in our challenges with
a much longer interval, which resulted in a rapid inflam-
matory response with systemic and local signs in both
challenges.
Recognition of LPS is an important event in the activation
of the innate immune response to Gram-negative bacteria.
LPS directly interacts with neutrophils through CD14 that
is expressed on cell surfaces [39]. The effective elimination
of the bacteria by neutrophils is important for the resolu-
tion of infection. If delayed, the disease can lead to devel-
opment of toxemia and septic shock [3]. Some
immunization effect could have occurred and resulted in
a faster response and milder disease (Figure 1), as well as
faster elimination of bacteria from the infected gland after
prior infection in a different quarter (Figure 2). Smith et
al. (1999) [40] showed that subcutaneous plus intramam-
mary immunization with E. coli J5 bacterin produced
enhanced antibody titers in milk and serum, but this not
Concentrations of SAA, LBP and Hp in serum and blood leukocyte counts in two consecutive E. coli challenges Figure 5
Concentrations of SAA, LBP and Hp in serum and blood leukocyte counts in two consecutive E. coli challenges. 
Mean concentrations of SAA, LBP and Hp in serum and mean blood leukocyte counts following two consecutive intramam-
mary challenges with E. coli at an interval of two weeks. Values are means for six cows with SEM represented by vertical bars.
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reduce clinical signs following challenge with E. coli. One
hypothesis for the potential mechanism of action of E. coli
vaccine is an enhanced PMN diapedesis caused by mam-
mary gland hyper-responsiveness [41]. Recently it was
suggested that the positive effect of vaccination is associ-
ated with a memory antibody response of IgG1 and IgG2
isotypes [8]. The immunological mechanism for the
immunization effect seen in the present study remains
unknown.
Only few studies have reported concentrations of acute
phase proteins in the milk during experimentally induced
E. coli mastitis. In the study by Jacobsen et al. [23], with a
lower dose (50 cfu) of E. coli, concentrations of SAA in
plasma were at a similar level, but those in the milk were
5-times as high as found here. In that study milk concen-
trations of SAA were highest in cows with severe mastitis
but did not differ between those with moderate or mild
signs. Concentrations of mammary-derived SAA in milk
were many times higher than concentrations of systemic
SAA in serum in their study and in ours. SAA has been sug-
gested to have an important role in the modulation of the
host response during infection [42,43]. It has been shown
to bind outer membrane protein A of E. coli, which may
also contribute to recognition of Gram-negative bacteria
of the host [44]. Rapid mammary SAA response is proba-
bly involved in the innate local protection against patho-
gens invading the udder.
The concentrations of Hp found in the milk were similar
to those reported in our previous study on E. coli mastitis
[34]. In a study using LPS challenge [15], the concentra-
tions of Hp increased by the end of the 12 h follow-up
period and were less than half of the concentrations seen
here. In the present and in the cited study where an ELISA
assay was used [15], the concentrations of Hp found in
milk were approximately half of those in serum. Hp assay
used here has not been validated for milk, thus the results
should be interpreted with some caution. The local pro-
duction of Hp seems not to be so pronounced as that of
SAA. Hp binds harmful molecules produced after tissue
damage, such as haemoglobin, which then becomes inac-
cessible for bacteria by limiting their growth [45]. Hp may
play a role in host defense against E. coli mastitis.
Concentrations of LBP in milk and plasma have been
shown to increase after intramammary challenge with LPS
[11] and E. coli [12,46]. Concentrations of LBP in blood
and milk found here are higher than reported in previous
studies using E. coli challenge models. In our study, con-
centrations in the milk were higher than those in blood,
contrary to the findings by Bannerman et al. [12]. Chal-
lenge models and other methods may be different, which
may partly explain differences between results from differ-
ent studies. LBP is a hepatocyte-derived protein that binds
LPS, facilitating the transfer of LPS to membrane-associ-
ated CD14 present on cells of monocytic lineage and neu-
trophils [47]. It enhances LPS-CD14-complex formation
and thus increases the sensitivity of the host innate
response to Gram-negative bacteria [47-49], having an
important role in the defense of the mammary gland. It is
possible that LBP is also produced locally by the mam-
mary epithelial cells, as also suggested by Bannerman et al.
[11], which would explain the high concentrations seen in
milk.
Conclusion
The concentrations of SAA and Hp in serum and milk in
this E. coli infection model were much higher than those
seen in experiments using Gram-positive pathogens,
which indicates the strong inflammation induced by E.
coli [22,19,50]. Acute phase proteins studied here have
been suggested as early markers of mastitis. They would
also be useful parameters to monitor the severity of mas-
titis, to be used, for example, in studies on pathogenesis
and effects of treatments. Repeated experimental
intramammary induction of the same animals with E. coli
bacteria has been used as a model in cross-over studies to
reduce the individual variation between different cows.
The significant differences between the consecutive chal-
lenges seen here suggest that in these studies the interval
between challenges should be longer than 2 weeks.
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